Literature DB >> 5336982

A trial of carbenoxolone sodium in the treatment of gastric ulceration.

S Bank, I N Marks, P E Palmer, A Groll, E van Eldik.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1967        PMID: 5336982

Source DB:  PubMed          Journal:  S Afr Med J


× No keyword cloud information.
  17 in total

Review 1.  Medical management of peptic ulcer with reference to anti-ulcer agents in other gastro-intestinal diseases.

Authors:  D W Piper; T R Heap
Journal:  Drugs       Date:  1972       Impact factor: 9.546

Review 2.  Carbenoxolone sodium.

Authors:  W Sircus
Journal:  Gut       Date:  1972-10       Impact factor: 23.059

Review 3.  Cyclic GMP and gastric acid secretion.

Authors:  M S Amer
Journal:  Am J Dig Dis       Date:  1974-01

4.  Histological changes in the gastric mucosa of chronic gastric ulcer patients treated with carbenoxolone.

Authors:  E Thomas; P Hall; I G Hislop
Journal:  Gut       Date:  1973-07       Impact factor: 23.059

5.  A trial of deglycyrrhizinated liquorice in the treatment of duodenal ulcer.

Authors:  H Feldman; T Gilat
Journal:  Gut       Date:  1971-06       Impact factor: 23.059

6.  Effect of low dosage of carbenoxolone sodium on gastric ulcer healing and acid secretion.

Authors:  J B Cocking; J N MacCaig
Journal:  Gut       Date:  1969-03       Impact factor: 23.059

7.  Clinical trial of deglycyrrhizinized liquorice in gastric ulcer.

Authors:  A G Turpie; J Runcie; T J Thomson
Journal:  Gut       Date:  1969-04       Impact factor: 23.059

8.  Medical treatment of gastric and duodenal ulcer.

Authors:  J H Baron
Journal:  Klin Wochenschr       Date:  1976-10-01

Review 9.  Carbenoxolone: a review of its pharmacological properties and therapeutic efficacy in peptic ulcer disease.

Authors:  R M Pinder; R N Brogden; P R Sawyer; T M Speight; R Spencer; G S Avery
Journal:  Drugs       Date:  1976       Impact factor: 9.546

10.  Effects of carbenoxolone sodium on stress-induced gastric damage in rats.

Authors:  W E Perkins; L Vars
Journal:  Br J Pharmacol       Date:  1973-04       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.